Chronic HBV carrier's acceptance of regular surveilling program in China.
10.1007/s11596-013-1113-z
- Author:
Qing FANG
1
;
You-hua HAO
;
Lei LI
;
Zhen-hua ZHANG
;
Jun-zhong WANG
;
Ming-fa CHEN
;
Jian KANG
;
Dong-liang YANG
Author Information
1. Devivision of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. iblfq@163.com
- Publication Type:Journal Article
- MeSH:
Adult;
Aged;
Aged, 80 and over;
Carrier State;
diagnosis;
epidemiology;
therapy;
China;
Chronic Disease;
Female;
Hepatitis B;
diagnosis;
epidemiology;
therapy;
Humans;
Longitudinal Studies;
Male;
Middle Aged;
Patient Compliance;
statistics & numerical data;
Population Surveillance;
methods;
Prevalence;
Young Adult
- From:
Journal of Huazhong University of Science and Technology (Medical Sciences)
2013;33(2):288-292
- CountryChina
- Language:English
-
Abstract:
Long-term compliance with regular surveillance is important for the prevention and timely management of chronic hepatitis B (CHB). However, there are no researches focusing on the compliance of hepatitis B virus infected patients in regular surveillance so far. The purpose of our study was to investigate the outpatient compliance with long-term regular surveillance in China. Data of 3257 CHB outpatients was pooled and analyzed to assess the outpatient's compliance with the long-term regular surveillance plan. In all outpatients, the non-follow-up and the follow-up group accounted for 73.2% and 26.8%, respectively. Among the follow-up outpatient's, only 48.9% received ongoing-follow-up and 51.1% were finally lost to follow-up; the median length of visiting duration was 25 months; and the predictive 1-, 2-, 3-, 4- and 5-year ongoing follow-up rate was 72.7%, 52.5%, 42.4%, 33.8%, and 26.3%, respectively. In conclusion, our survey proved that the regular long-term surveillance on Chinese chronic HBV carrier is difficult to be fully implemented. A large proportion of outpatients do not receive routine follow-up and are at risk of treatment delay due to various social reasons.
